Number of the records: 1
Impact of the 21-gene recurrence score assay in adjuvant chemotherapy selection for node-negative, hormone receptor-positive breast cancer in the Chinese population
SYS 0115229 LBL 00000naa^^22^^^^^^^^450 005 20150911120808.0 100 $a 20150902a2015 m y0sloy0103 ba 101 0-
$a eng $d eng 102 $a SK 200 1-
$a Impact of the 21-gene recurrence score assay in adjuvant chemotherapy selection for node-negative, hormone receptor-positive breast cancer in the Chinese population $f Y. N. Zhang ... [et al.] 215 $c ilustr., grafy, tab. 320 $a Bibliogr. odkazy 320 $a Res. angl. 463 -1
$1 001 sllk_un_cat*0114217 $1 011 $a 0028-2685 $1 200 1 $a Neoplasma $e journal of experimental and clinical oncology $f Cancer Research Institute of the Slovak Academy of Sciences $v Vol. 62, no. 4 (2015), s. 658-665 $1 210 $a Bratislava $c AEPress $d 2015 $1 215 $a s. 509-682 541 1-
$a Vplyv testu skóre recidívy 21-génu na výber adjuvantnej chemoterapie pre negatívne noduly, pozitívne hormonálne receptory rakoviny prsníka u čínskej populácie $z slo 606 1-
$3 sllk_un_auth*d001943 $a nádory prsníka $x farmakoterapia $x genetika $x patológia $2 mesh 606 1-
$3 sllk_un_auth*d017024 $a chemoterapia adjuvantná $2 mesh 606 1-
$3 sllk_un_auth*d009364 $a recidíva nádoru, lokálna $x genetika $2 mesh 606 2-
$3 sllk_un_auth*d011960 $a receptory estrogénové $2 mesh 606 2-
$3 sllk_un_auth*d011980 $a receptory progesterónové $2 mesh 606 2-
$3 sllk_un_auth*d002985 $a protokoly klinické $2 mesh 606 2-
$3 sllk_un_auth*d003657 $a rozhodovanie $2 mesh 606 2-
$3 sllk_un_auth*d011446 $a štúdie prospektívne $2 mesh 606 2-
$3 sllk_un_auth*d044382 $a skupiny populačné $2 mesh 607 $3 sllk_un_auth*d002681 $a Čína $2 mesh 610 2-
$a skóre recidívy 701 -1
$3 sllk_un_auth*0036961 $a Zhang $b Y. N. $p Department of Breast Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China $4 070 801 -0
$a SK $b BA006 $c 20150902 $g AACR2
Number of the records: 1